Clinical Trial Update: Evaluation of the Efficacy of Almotriptan and Ubrogepant for the Acute Treatment of Migraine [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating almotriptan and ubrogepant for acute treatment of migraine has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine Without Aura
• Migraine with Aura

Drugs mentioned

• Axert (Almotriptan)
• Ubrelvy (ubrogepant)

Snippet

Sponsor: Messoud Ashina, MD | Conditions: Migraine With Aura, Migraine Without Aura | Phase 4 | Status: TERMINATED